Literature DB >> 21820841

Improving retrieval rates of temporary inferior vena cava filters.

Antonios P Gasparis1, Georgios Spentzouris, Robert J Meisner, Doreen Elitharp, Nicos Labropoulos, Apostolos Tassiopoulos.   

Abstract

PURPOSE: Most studies have shown that the rate of inferior vena cava filter (IVCF) retrieval rarely exceeds 30%. A review of practices in our own institution revealed similar results (18%). Within the last year, few centers have demonstrated improved retrieval rates. Our hypothesis was that developing a dedicated program would improve IVCF retrieval. We report the results of an ongoing study following the development of this program.
METHODS: This is a cohort of nontrauma consecutive patients who had an IVCF placed by the vascular service over a 12-month period (January 2010-January 2011) and were followed prospectively. A dedicated nurse practitioner was responsible in developing a database, maintaining contact with all the patients, and ensuring that arrangements were made for retrieval when indications for IVCF protection were no longer present. Demographics, indication for filter placement, timing to filter retrieval, and complications during placement and retrieval were prospectively collected. Retrieval rate was compared to the baseline institution data.
RESULTS: During the study period, 42 patients had an IVCF placed. There were 27 men and 15 women with a mean age of 58 (25 to 88 years old). Two patients were excluded (one due to mortality and one had multiple filters) leaving 40 patients in the study. Indications for IVCF placement were absolute in 23 of 40 patients (58%), relative in 10 of 40 patients (25%), while seven patients (17%) had an IVCF placed for prophylaxis as they were considered high risk for pulmonary embolism (PE) and could not receive any chemical regimen. During follow-up, five filters were converted to permanent. Therefore, retrieval was successful in 19 of 22 patients with an 86% success rate and no complications. Median time to retrieval was 21 days ranging from 4 to 140 days. Retrieval rate for IVCFs designated as temporary at the time of placement was 70% (19 of 27), which was significantly higher compared to our baseline data of 18% (P < .001).
CONCLUSION: Initial data show that a dedicated program that closely monitors patients with temporary IVCFs for ongoing need of filter prophylaxis can result in high retrieval rates. The endurance and long-term success of such a program needs to be further validated.
Copyright © 2011 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21820841     DOI: 10.1016/j.jvs.2011.05.094

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

1.  Persistently low inferior vena cava filter retrieval rates in a population-based cohort.

Authors:  Abhisekh Mohapatra; Nathan L Liang; Rabih A Chaer; Edith Tzeng
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2018-11-12

2.  Improving the retrieval rate of inferior vena cava filters with a multidisciplinary team approach.

Authors:  Elica Inagaki; Alik Farber; Mohammad H Eslami; Jeffrey J Siracuse; Denis V Rybin; Shayna Sarosiek; J Mark Sloan; Jeffrey Kalish
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2016-02-28

3.  Non-retrieval of inferior vena cava filters as a patient safety concern: evaluation of a new process improvement project to increase retrieval rates in a vascular and interventional radiology clinic.

Authors:  Joshua Brown; Jeffery Talbert; Ryan Pennington; Qiong Han; Driss Raissi
Journal:  Patient Saf Surg       Date:  2018-03-20

4.  Practice Patterns of Inferior Vena Cava Filter Placement and Factors That Predict Retrieval Rates: A Single-Center Institution and Review of the Literature.

Authors:  Ming Y Lim; Ricardo Yamada; Marcelo Guimaraes; Charles S Greenberg
Journal:  J Clin Med Res       Date:  2018-09-10

Review 5.  Vena Cava Filters: Toward Optimal Strategies for Filter Retrieval and Patients' Follow-Up.

Authors:  Kiara Rezaei-Kalantari; David C Rotzinger; Salah D Qanadli
Journal:  Front Cardiovasc Med       Date:  2022-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.